Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06149468

CAP48 - Autism in Children and Adolescents

Evaluation and follow-up of children diagnosed with an autism spectrum disorder in French-speaking Belgium in order to optimize diagnostic protocols, the quality of care required and its accessibility, and to determine the impact of an autism spectrum disorder on schooling, family and society.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Autism Spectrum Disorder Child Development Disorders, Pervasive Mental Disorders Neurodevelopmental Disorders

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

The aims of the research project:

  • To collect a wide range of data in order to improve knowledge of children with autism spectrum disorder (ASD) in French-speaking Belgium by prospectively including all children and adolescents making a request to the centres of reference. The creation of a common database will make it possible to collect general socio-demographic, geographical and epidemiological data, to characterise the different profiles and to accurately monitor developmental trajectories.
  • Evaluate the feasibility and practical implementation of the treatment proposed following a diagnosis of ASD in a child.
  • Implement protocols to improve the quality of care for beneficiaries.
  • To enable the development of fundamental research protocols. Many questions remain unanswered about the genetic, neuro-cognitive and linguistic characteristics of autism. Only rigorous studies carried out on large, carefully defined samples can advance research.
  • Increase public knowledge and understanding of the ASD.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • children/adolescents (under 18 years of age) who apply to an autism reference center or who are followed up in an autism reference center from French-speaking region of Belgium.

Exclusion criteria

  • refusal by the family to allow their child's data to be included in the database.

Treatment and study plan

inclusion in the register

Other

socio-demographic data collection and proposed therapy

Primary outcomes

  1. Creation of an ADS register

    Time frame: Throughout the entire study, approximately during 5 years

    creation of a common ASD register to collect general sociodemographic, geographic and epidemiological data, characterize the different patient profiles and accurately track development trajectories

Secondary outcomes

  1. Feasability assessment

    Time frame: Throughout the entire study, approximately during 5 years

    Evaluate the feasibility and practical realization of the proposed care following a diagnosis of ASD in a child and implement protocols to improve the quality of therapy.

  2. Protocols development

    Time frame: Throughout the entire study, approximately during 5 years

    Enable the development of fundamental research protocols: genetic, neurocognitive and linguistic

  3. Schooling evaluation

    Time frame: Throughout the entire study, approximately during 5 years

    Evaluate the schooling of children with ASD of all ages

Study contacts

Contact information is provided by the study sponsor or research team.

Marie-Cécile Nassogne, Prof

CONTACT

[email protected]

027641061

Marine Houssa, PhD

CONTACT

[email protected]

010474688 ext. 74688

Sponsors and collaborators

Lead sponsor

Université Catholique de Louvain

Other

Collaborators

  • University of Mons
  • Université Libre de Bruxelles
  • Université de Liège
  • Université de Namur

Registry information

Official study title

CAP48 Medical Research Project: Autism Spectrum Disorders in Children and Adolescents

Acronym: CAP48-ASD

Important dates

Study start
2023
Primary completion
2028
Study completion
2028
First posted
Nov 29, 2023
Registry last updated
May 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.